المؤلفون: Heuser, M, Freeman, Sd, Ossenkoppele, Gj, Buccisano, F, Hourigan, Cs, Ngai, Ll, Tettero, Jm, Bachas, C, Baer, C, Béné, Mc, Buecklein, V, Czyz, A, Denys, B, Dillon, R, Feuring-Buske, M, Guzman, Ml, Haferlach, T, Han, L, Herzig, Jk, Jorgensen, Jl, Kern, W, Konopleva, My, Lacombe, F, Libura, M, Majchrzak, A, Maurillo, L, Ofran, Y, Philippé, J, Plesa, A, Preudhomme, C, Ravandi, F, Roumier, C, Subklewe, M, Thol, F, van de Loosdrecht, Aa, van der Reijden, Ba, Venditti, A, Wierzbowska, A, Valk, Pjm, Wood, Bl, Walter, Rb, Thiede, C, Döhner, K, Roboz, Gj, Cloos, J

مصطلحات موضوعية: Settore MED/15

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3667::79de21a1db642f51cd6d9d8de04d4eef
http://hdl.handle.net/2108/281268

المؤلفون: Hernández-Sánchez A; Hematology Department, University Hospital of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center of Salamanca (IBMCC, USAL-CSIC), Salamanca, Spain., González T; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center of Salamanca (IBMCC, USAL-CSIC), Salamanca, Spain., Sobas M; Wroclaw Medical University, Wroclaw, Poland., Sträng E; Charité Universitätsmedizin Berlin, Berlin, Germany., Castellani G; DIMES, University of Bologna, Bologna, Italy., Abáigar M; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center of Salamanca (IBMCC, USAL-CSIC), Salamanca, Spain., Valk PJM; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Villaverde Ramiro Á; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center of Salamanca (IBMCC, USAL-CSIC), Salamanca, Spain., Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Metzeler KH; University of Leipzig, Leipzig, Germany., Azibeiro R; Hematology Department, University Hospital of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Tettero JM; Department of Hematology, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands., Martínez-López J; Hospital Universitario 12 de Octubre, Madrid, Spain., Pratcorona M; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Martínez Elicegui J; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center of Salamanca (IBMCC, USAL-CSIC), Salamanca, Spain., Mills KI; Patrick G Johnston Centre for Cancer Research, Queen's University, Belfast, UK., Thiede C; University of Technics Dresden Medical Department, Dresden, Germany., Sanz G; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Turki AT; Marienhospital University Hospital, Ruhr-University Bochum, Bochum, Germany.; Universitätsklinikum Essen, Essen, Germany., Reinhardt D; Department of Pediatrics III, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Schulze-Rath R; Bayer AG, Pharmaceuticals Division, Berlin, Germany., Barbus M; AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany., Hernández-Rivas JM; Hematology Department, University Hospital of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center of Salamanca (IBMCC, USAL-CSIC), Salamanca, Spain.; Department of Medicine, University of Salamanca, Salamanca, Spain., Huntly B; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Ossenkoppele G; Department of Hematology, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands., Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Bullinger L; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany. lars.bullinger@charite.de.

المصدر: Leukemia [Leukemia] 2024 Jul 04. Date of Electronic Publication: 2024 Jul 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

المؤلفون: Tettero JM; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Heidinga ME; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Mocking TR; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Fransen G; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Kelder A; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Scholten WJ; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Snel AN; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Ngai LL; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Bachas C; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., van de Loosdrecht AA; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Ossenkoppele GJ; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., de Leeuw DC; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Cloos J; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands. j.cloos@amsterdamumc.nl.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands. j.cloos@amsterdamumc.nl., Janssen JJWM; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.

المصدر: Leukemia [Leukemia] 2024 Mar; Vol. 38 (3), pp. 630-639. Date of Electronic Publication: 2024 Jan 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Hemodilution* , Leukemia, Myeloid, Acute*/diagnosis , Leukemia, Myeloid, Acute*/therapy , Leukemia, Myeloid, Acute*/genetics, Humans ; Flow Cytometry/methods ; Bone Marrow ; Neoplasm, Residual/diagnosis ; Prognosis

المؤلفون: Dall'Olio D; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italia., Sträng E; Department of Hematology, Oncology and Cancer Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Turki AT; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.; Department of Hematology and Oncology, Marienhospital University Hospital, Ruhr-University Bochum, Bochum, Germany., Tettero JM; Department of Hematology, Amsterdam UMC location Vrije Universiteit, Amsterdam, the Netherlands., Barbus M; AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany., Schulze-Rath R; Bayer AG, Berlin, Germany., Elicegui JM; Molecular Genetics in Oncohematology, Institute of Biomedical Research of Salamanca, Salamanca, Spain., Matteuzzi T; Department of Physics and Astronomy, University of Florence, Sesto Fiorentino, Italy., Merlotti A; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italia.; Physics and Astronomy Department, University of Bologna, Bologna, Italy., Carota L; Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy., Sala C; Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy., Della Porta MG; Comprehensive Cancer Center, IRCCS Humanitas Clinical and Research Center and Department of Biomedical Sciences, Humanitas University, Milan, Italy., Giampieri E; Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy., Hernández-Rivas JM; Molecular Genetics in Oncohematology, Institute of Biomedical Research of Salamanca, Salamanca, Spain.; Hematology Department, University Hospital of Salamanca, Salamanca, Spain.; Cancer Research Center of Salamanca, Salamanca, Spain., Bullinger L; Department of Hematology, Oncology and Cancer Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Castellani G; Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy.

مؤلفون مشاركون: with the HARMONY Healthcare Alliance Consortium

المصدر: PLoS computational biology [PLoS Comput Biol] 2024 Feb 02; Vol. 20 (2), pp. e1011299. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7358 (Electronic) Linking ISSN: 1553734X NLM ISO Abbreviation: PLoS Comput Biol Subsets: MEDLINE

مواضيع طبية MeSH: Hematology* , Leukemia, Myeloid, Acute*/genetics, Humans ; Genomics ; Chromosome Aberrations

المؤلفون: Tettero JM; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands., Buisman Y; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands., Ngai LL; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands., Bachas C; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands., Gjertsen BT; Haukeland University Hospital, Bergen, Norway., Kelder A; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands., van de Loosdrecht AA; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands., Manz MG; Department of Medical Oncology and Hematology, University Hospital, Zurich, Switzerland.; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland., Pabst T; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.; Department of Medical Oncology, Inselspital, University Hospital, Bern, Switzerland., Scholten W; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands., Ossenkoppele GJ; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands., Cloos J; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands., de Leeuw DC; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.

المصدر: HemaSphere [Hemasphere] 2023 Nov 21; Vol. 7 (12), pp. e981. Date of Electronic Publication: 2023 Nov 21 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

المؤلفون: Tettero JM; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Dakappagari N; Navigate BioPharma (a Novartis Subsidiary), Carlsbad, California, USA., Heidinga ME; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Oussoren-Brockhoff Y; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Hanekamp D; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Pahuja A; Navigate BioPharma (a Novartis Subsidiary), Carlsbad, California, USA., Burns K; Navigate BioPharma (a Novartis Subsidiary), Carlsbad, California, USA., Kaur P; Navigate BioPharma (a Novartis Subsidiary), Carlsbad, California, USA., Alfonso Z; Navigate BioPharma (a Novartis Subsidiary), Carlsbad, California, USA., van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Te Marvelde JG; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Hobo W; Department of Laboratory Medicine-Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Slomp J; Department of Clinical Chemistry, Medisch Spectrum Twente/Medlon, Enschede, The Netherlands., Bachas C; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Kelder A; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Nguyen K; Navigate BioPharma (a Novartis Subsidiary), Carlsbad, California, USA., Cloos J; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.

المصدر: Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2023 Nov; Vol. 104 (6), pp. 426-439. Date of Electronic Publication: 2023 Sep 28.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 101235690 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4957 (Electronic) Linking ISSN: 15524949 NLM ISO Abbreviation: Cytometry B Clin Cytom Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/diagnosis, Humans ; Flow Cytometry/methods ; Neoplasm, Residual/diagnosis ; Immunophenotyping

المؤلفون: Tettero JM; Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands., Ngai LL; Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands., Bachas C; Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands., Breems DA; Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium., Fischer T; Otto von Guericke University Hospital Magdeburg, Magdeburg, Germany., Gjertsen BT; Haukeland University Hospital, Bergen, Norway., Gradowska P; Dutch-Belgian Hemato-Oncology Cooperative Group Data Center-Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Griskevicius L; Vilnius University Hospital Santaros Klinikos and Vilnius University, Vilnius, Lithuania., Janssen JJWM; Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands., Juliusson G; Skanes University Hospital, Lund, Sweden., Maertens J; University Hospital Gasthuisberg, Leuven, Belgium., Manz MG; University Hospital, Zurich, Switzerland; Swiss Group for Clinical Cancer Research(SAKK), Bern, Switzerland., Pabst T; Swiss Group for Clinical Cancer Research(SAKK), Bern, Switzerland; Department of Medical Oncology, Inselspital; University Hospital, Bern, Switzerland., Passweg J; Swiss Group for Clinical Cancer Research(SAKK), Bern, Switzerland; University Hospital, Basel, Switzerland., Porkka K; Helsinki University Hospital Cancer Center, Helsinki, Finland., Valk PJM; Erasmus University Medical Center (MC) and Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Löwenberg B; Erasmus University Medical Center (MC) and Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Ossenkoppele GJ; Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands., Cloos J; Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands. j.cloos@amsterdamumc.nl.

المصدر: Haematologica [Haematologica] 2023 Oct 01; Vol. 108 (10), pp. 2794-2798. Date of Electronic Publication: 2023 Oct 01.

نوع المنشور: Letter

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Leukemia, Myeloid, Acute*/therapy, Humans ; Transplantation, Homologous ; Neoplasm, Residual ; Recurrence ; Transplantation Conditioning

المؤلفون: Ngai LL; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Hanekamp D; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.; Department of Hematology, Erasmus MC, Rotterdam, Netherlands., Janssen F; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Carbaat-Ham J; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Hofland MAMA; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Fayed MMHE; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Kelder A; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Oudshoorn-van Marsbergen L; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Scholten WJ; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Snel AN; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Bachas C; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Tettero JM; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Breems DA; Department of Hematology, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium., Fischer T; Department of Hematology and Oncology, Otto von Guericke University Hospital Magdeburg, Magdeburg, Germany., Gjertsen BT; Department of Clinical Science, Haukeland University Hospital, Bergen, Norway., Griškevičius L; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos and Vilnius University, Vilnius, Lithuania., Juliusson G; Department of Hematology, Skanes University Hospital, Lund, Sweden., van de Loosdrecht AA; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Maertens JA; Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium., Manz MG; Department of Medical Oncology and Hematology, University Hospital, Zurich, Switzerland.; Swiss Group for Clinical Cancer Research, Bern, Switzerland., Pabst T; Swiss Group for Clinical Cancer Research, Bern, Switzerland.; Department of Medical Oncology, Inselspital, University Hospital, Bern, Switzerland., Passweg JR; Swiss Group for Clinical Cancer Research, Bern, Switzerland.; Department of Hematology, University Hospital, Basel, Switzerland., Porkka K; Department of Hematology, Helsinki University Hospital Cancer Center, Helsinki, Finland., Valk PJM; Department of Hematology, Erasmus MC, Rotterdam, Netherlands., Gradowska P; Dutch-Belgian Hemato-Oncology Cooperative Group Data Center-Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Löwenberg B; Department of Hematology, Erasmus MC, Rotterdam, Netherlands., de Leeuw DC; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Janssen JJWM; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Ossenkoppele GJ; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Cloos J; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Cancer Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.

المصدر: Blood [Blood] 2023 May 25; Vol. 141 (21), pp. 2657-2661.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*, Humans ; Prognosis ; Antigens, CD34 ; ADP-ribosyl Cyclase 1 ; Stem Cells ; Neoplastic Stem Cells ; Flow Cytometry

المؤلفون: Tettero JM; Department of Hematology, Amsterdam Univerisity Medical Centers location Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, Netherlands., Al-Badri WKW; Department of Hematology, Amsterdam Univerisity Medical Centers location Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Ngai LL; Department of Hematology, Amsterdam Univerisity Medical Centers location Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, Netherlands., Bachas C; Department of Hematology, Amsterdam Univerisity Medical Centers location Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, Netherlands., Breems DA; Department of Hematology, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium., van Elssen CHMJ; Department of Internal Medicine, Division of Hematology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands., Fischer T; Department of Hematology and Oncology, Otto von Guericke University Hospital Magdeburg, Magdeburg, Germany., Gjertsen BT; Department of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway., van Gorkom GNY; Department of Internal Medicine, Division of Hematology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands., Gradowska P; The Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) Data Center, Department of Hematology, Erasmus Medical Center (MC) Cancer Institute, Rotterdam, Netherlands., Greuter MJE; Department of Epidemiology and Data Science, Amsterdam Univerisity Medical Centers, location Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Griskevicius L; Hematology, Oncology, Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos and Vilnius University, Vilnius, Lithuania., Juliusson G; Department of Hematology, Skanes University Hospital, Lund, Sweden., Maertens J; Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium., Manz MG; Department of Medical Oncology and Hematology, University Hospital, Zurich, Switzerland.; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland., Pabst T; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.; Department of Medical Oncology, Inselspital, University Hospital, Bern, Switzerland., Passweg J; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.; Department of Hematology, University Hospital, Basel, Switzerland., Porkka K; Department of Hematology, Helsinki University Hospital Cancer Center, Helsinki, Finland., Löwenberg B; Department of Hematology, Erasmus University Medical Center (MC) and Erasmus MC Cancer Institute, Rotterdam, Netherlands., Ossenkoppele GJ; Department of Hematology, Amsterdam Univerisity Medical Centers location Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, Netherlands., Janssen JJWM; Department of Hematology, Amsterdam Univerisity Medical Centers location Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, Netherlands., Cloos J; Department of Hematology, Amsterdam Univerisity Medical Centers location Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, Netherlands.

المصدر: Frontiers in oncology [Front Oncol] 2022 Oct 10; Vol. 12, pp. 999822. Date of Electronic Publication: 2022 Oct 10 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Heuser M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Freeman SD; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Ossenkoppele GJ; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Buccisano F; Department of Biomedicine and Prevention, Hematology, University Tor Vergata, Rome, Italy., Hourigan CS; Laboratory of Myeloid Malignancy, Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, MD., Ngai LL; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Tettero JM; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Bachas C; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Baer C; MLL Munich Leukemia Laboratory, Munich, Germany., Béné MC; Department of Hematology and Biology, Centre Hospitalier Universitaire (CHU) Nantes, Nantes, France., Bücklein V; Department of Medicine III, University Hospital, Ludwig Maximilian University Munich, Munich, Germany., Czyz A; Department of Hematology, Blood Neoplasms, and Bone Marrow Transplantation, Wrocław Medical University, Wrocław, Poland., Denys B; Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University., Dillon R; Department of Medical and Molecular Genetics, King's College, London, United Kingdom., Feuring-Buske M; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Guzman ML; Department of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Han L; Department of Leukemia and., Herzig JK; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Jorgensen JL; The Department of Hematopathology, MD Anderson Cancer Center, Houston, TX., Kern W; MLL Munich Leukemia Laboratory, Munich, Germany., Konopleva MY; Department of Leukemia and., Lacombe F; Hematology Biology, Flow Cytometry, Bordeaux University Hospital, Pessac, France., Libura M; Medical University of Warsaw, Warsaw, Poland., Majchrzak A; Department of Experimental Hematology, Copernicus Memorial Hospital, Lodz, Poland., Maurillo L; Department of Biomedicine and Prevention, Hematology, University Tor Vergata, Rome, Italy., Ofran Y; Department of Hematology, Shaare Zedek Medical Center Faculty of Medicine Hebrew University, Jerusalem Israel., Philippe J; Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University., Plesa A; Department of Hematology Laboratory, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Lyon, France., Preudhomme C; Laboratory of Hematology, CHU Université de Lille, Lille, France., Ravandi F; Department of Leukemia and., Roumier C; Laboratory of Hematology, CHU Université de Lille, Lille, France., Subklewe M; Department of Medicine III, University Hospital, Ludwig Maximilian University Munich, Munich, Germany., Thol F; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., van der Reijden BA; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Venditti A; Department of Biomedicine and Prevention, Hematology, University Tor Vergata, Rome, Italy., Wierzbowska A; Department of Hematology, Medical University of Lodz, Lodz, Poland., Valk PJM; Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands., Wood BL; Department of Hematopathology, Children's Hospital Los Angeles, CA., Walter RB; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Thiede C; Department of Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany; and.; AgenDix GmbH, Dresden, Germany., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Roboz GJ; Department of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY., Cloos J; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.

المصدر: Blood [Blood] 2021 Dec 30; Vol. 138 (26), pp. 2753-2767.

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute/*diagnosis , Neoplasm, Residual/*diagnosis, Europe ; Flow Cytometry/methods ; High-Throughput Nucleotide Sequencing/methods ; Humans ; Leukemia, Myeloid, Acute/genetics ; Neoplasm, Residual/genetics ; Prognosis